Efficacy and safety of intravenous neridronate in pediatric bone loss associated to Crohn's disease: a case report.
A Diamanti, C Noto, M S Basso, B Papadatou, F Bracci, M Castro
Index: Clin. Exp. Rheumatol. 27(1) , 165, (2009)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
2010-09-01
[Eur. J. Pharm. Biopharm. 76(1) , 120-6, (2010)]
Intramuscular neridronate in postmenopausal women with low bone mineral density.
2008-11-01
[Calcif. Tissue Int. 83(5) , 301-7, (2008)]
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
2009-09-01
[Mini Rev. Med. Chem. 9(9) , 1052-63, (2009)]
Neridronic acid for the treatment of bone metabolic diseases.
2009-10-01
[Expert Opin. Drug Metab. Toxicol. 5(10) , 1305-11, (2009)]
Taurine deficiency in thalassemia major-induced osteoporosis treated with neridronate.
2010-04-01
[Biomed. Pharmacother. 64(4) , 271-4, (2010)]